Asston Pharma Approves Preferential Issue of ₹27.7 Cr Equity

Asston Pharmaceuticals Ltd announced the approval of a preferential issue of up to 24,10,431 equity shares at ₹115 per share, aggregating ₹27.71 crore. The shares will be issued to non-promoter category investors on a preferential basis for cash. This issuance is subject to shareholder and regulatory approvals. Additionally, the company approved convening an Extraordinary General Meeting (EGM) on July 31, 2026, to seek member approval for the preferential allotment. The board meeting was held on July 2, 2026, from 3:00 PM to 5:00 PM.